Cargando…

The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making

SIMPLE SUMMARY: This retrospective analysis evaluated the prognostic implications of lymphovascular invasion (LVI) associated with adjuvant chemotherapy in 1634 patients with pT3N0 colorectal cancer. Extensive pathologic review and dual immunohistochemical (IHC) staining with CD31 and D2-40 were und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hayoung, Yoo, Seung-Yeon, Park, In Ja, Hong, Seung-Mo, Lim, Seok-Byung, Yu, Chang Sik, Kim, Jin Cheon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221415/ https://www.ncbi.nlm.nih.gov/pubmed/35740498 http://dx.doi.org/10.3390/cancers14122833

Ejemplares similares

Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy
por: Lee, Kwang Suk, et al.
Publicado: (2015)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Increased Expression of ATG10 in Colorectal Cancer Is Associated with Lymphovascular Invasion and Lymph Node Metastasis
por: Jo, Yoon Kyung, et al.
Publicado: (2012)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022)

Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients
por: Zhang, Linjie, et al.
Publicado: (2023)

Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
por: Lee, Suk Jun, et al.
Publicado: (2023)

Can clinicopathologic high-risk features in T3N0 colon cancer be reliable prognostic factors?
por: Lee, Hyun Gu, et al.
Publicado: (2023)

Prognostic Nomogram for Postoperative Hypopharyngeal Squamous Cell Carcinoma to Assist Decision Making for Adjuvant Chemotherapy
por: Zhang, Di, et al.
Publicado: (2022)

Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer
por: Lee, Yu Kyung, et al.
Publicado: (2018)

Making Decisions with Unknown Sensory Reliability
por: Deneve, Sophie
Publicado: (2012)

Lymphovascular Invasion and the Decision for Postmastectomy Radiation Therapy: A Cautionary Case Report
por: Jensen, J. Arthur, et al.
Publicado: (2019)

Making adjuvant therapy decisions with uncertain data
por: Gyawali, B, et al.
Publicado: (2019)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion
por: Nam, Seung-Joo, et al.
Publicado: (2022)

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase
por: Narimatsu, Takahiro, et al.
Publicado: (2019)

Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
por: Jeong, Jae-Uk, et al.
Publicado: (2019)

Prognostic Nomogram for Early Gastric Cancer After Surgery to Assist Decision-Making for Treatment With Adjuvant Chemotherapy
por: Zhang, Chao, et al.
Publicado: (2022)

Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively
por: Kim, Jin Cheon, et al.
Publicado: (2018)

Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis
por: Pan, Siwei, et al.
Publicado: (2021)

The impact of Oncotype DX testing on adjuvant chemotherapy decision making in 1–3 node positive breast cancer
por: Malam, Yogeshkumar, et al.
Publicado: (2021)

Primary testicular carcinoid tumor with marked lymphovascular invasion
por: Lee, Hyun Jung, et al.
Publicado: (2021)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Prediction of lymphovascular space invasion in patients with endometrial cancer
por: Kim, Sang Il, et al.
Publicado: (2021)

Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database
por: Park, Yong Hyun, et al.
Publicado: (2016)

Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan
por: Lee, Sun-Young, et al.
Publicado: (2017)

Updates on Lymphovascular Invasion in Breast Cancer
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors
por: Kwon, Mi Jung, et al.
Publicado: (2016)

Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients
por: Wang, Xiaofei, et al.
Publicado: (2021)

A Case Report of Breast Cancer with Extensive Pulmonary Lymphovascular Tumor Emboli
por: Yang, Yaewon, et al.
Publicado: (2012)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Erratum: Correction of Acknowledgments. ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?
por: Kim, Jee Yeon, et al.
Publicado: (2015)

Impact of adjuvant chemotherapy for gliomatosis cerebri
por: Kong, Doo-Sik, et al.
Publicado: (2010)

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study
por: To, Yat Hang, et al.
Publicado: (2023)

Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients’ treatment decisions
por: Jorgensen, Mikaela L, et al.
Publicado: (2013)

Inguinal prolapse of a retroperitoneal lymphovascular malformation
por: Trivedi, Hersh M., et al.
Publicado: (2021)

Reliability of the Evidence to Guide Decision-Making in Acupuncture for Functional Dyspepsia
por: Huang, Jinke, et al.
Publicado: (2022)

Actual compliance to adjuvant chemotherapy in gastric cancer
por: Kim, Dong-Wook, et al.
Publicado: (2019)

Chemotherapy-Associated Hepatopathy in Korean Colorectal Cancer Liver Metastasis Patients: Oxaliplatin-Based Chemotherapy and Sinusoidal Injury
por: Nam, Soo Jeong, et al.
Publicado: (2012)

Short-term outcomes of Early versus conventional adjuvant chemotherapy in stage III colon cancer: randomized clinical trial
por: Lee, Kyung Ha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pla8c01safn8veb5i5k15a21jo